These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 24729)

  • 21. Effects of various inhibitors of tyrosine hydroxylase and dopamine beta-hydroxylase on rat self-stimulation after reserpine treatment.
    Stinus L; Thierry AM; Cardo B
    Psychopharmacologia; 1976 Feb; 45(3):287-94. PubMed ID: 2944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine.
    Phillips AG; Fibiger HC
    Science; 1973 Feb; 179(4073):575-7. PubMed ID: 4686463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments.
    Cooper BR; Cott JM; Breese GR
    Psychopharmacologia; 1974 Jul; 37(3):235-48. PubMed ID: 4851731
    [No Abstract]   [Full Text] [Related]  

  • 24. Self-stimulation at the lateral hypothalamus and locus coeruleus after specific unilateral lesions of the dopamine system.
    Koob GF; Fray PJ; Iversen SD
    Brain Res; 1978 May; 146(1):123-40. PubMed ID: 647383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
    Curet O; De Montigny C; Blier P
    Eur J Pharmacol; 1992 Oct; 221(1):59-70. PubMed ID: 1333978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior.
    Mohammed AK; Danysz W; Ogren SO; Archer T
    Neurosci Lett; 1986 Feb; 64(2):139-44. PubMed ID: 3008041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacological and anatomical substrates of the amphetamine response in the rat.
    Creese I; Iversen SD
    Brain Res; 1975 Jan; 83(3):419-36. PubMed ID: 234270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 6-hydroxydopamine lesions of locus coeruleus on startle in rats.
    Adams LM; Geyer MA
    Psychopharmacology (Berl); 1981; 73(4):394-8. PubMed ID: 6789365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.
    Herberg LJ; Stephens DN; Franklin KB
    Pharmacol Biochem Behav; 1976 May; 4(5):575-82. PubMed ID: 133356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The actions of amphetamine on neurotransmitters: a brief review.
    Moore KE
    Biol Psychiatry; 1977 Jun; 12(3):451-62. PubMed ID: 17437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presynaptic alpha-adrenergic mediation of self-stimulation in locus coeruleus in rats treated neonatally with 6-hydroxydopamine.
    Umemoto M; Olds ME
    Brain Res; 1981 Aug; 219(1):107-19. PubMed ID: 6266595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norepinephrine reward pathways: role of self-stimulation, memory consolidation, and schizophrenia.
    Stein L
    Nebr Symp Motiv; 1975; 22():113-59. PubMed ID: 1688
    [No Abstract]   [Full Text] [Related]  

  • 33. Bromocriptine promotes recovery of self-stimulation in 6-hydroxydopamine-lesioned rats.
    Carey RJ
    Pharmacol Biochem Behav; 1983 Feb; 18(2):273-6. PubMed ID: 6403950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in norepinephrine and dopamine neurotransmitter storage systems.
    Sanghera MK; German DC; Kiser RS; Shore PA
    Brain Res Bull; 1979; 4(2):217-21. PubMed ID: 223744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral 6-hydroxydopamine lesions of dopamine neurons produce bilateral self-stimulation deficits.
    Carey RJ
    Behav Brain Res; 1982 Oct; 6(2):101-14. PubMed ID: 6814462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
    German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK
    Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Roles of noradrenergic and dopaminergic systems in the self-stimulation behavior of the substantia nigra].
    Hasegawa K
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):827-35. PubMed ID: 1035186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of morphine and D-amphetamine on self-stimulation from closely adjacent regions in rat midbrain.
    Liebman J; Segal DS
    Brain Res; 1977 Nov; 136(1):103-17. PubMed ID: 589437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intraventricular 6-hydroxydopamine and replacement therapy with norepinephrine, dopamine, and serotonin on self-stimulation in diencephalic and mesencephalic regions in the rat.
    Olds ME
    Brain Res; 1975 Nov; 98(2):327-42. PubMed ID: 1182523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of neurotoxic lesions of the ascending monoamine pathways in the rat brain.
    Heybach JP; Coover GD; Lints CE
    J Comp Physiol Psychol; 1978 Feb; 92(1):58-70. PubMed ID: 627639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.